Exploratory Evaluation of EGFR-Targeted Anti-Tumor Drugs for Lung Cancer Based on Lung-on-a-Chip
Open Access
- 9 August 2022
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 12 (8) , 618
Abstract
In this study, we used three-dimensional (3D) printing to prepare a template of a microfluidic chip from which a polydimethylsiloxane (PDMS)lung chip was successfully constructed. The upper and lower channels of the chip are separated by a microporous membrane. The upper channel is seeded with lung cancer cells, and the lower channel is seeded with vascular endothelial cells and continuously perfused with cell culture medium. This lung chip can simulate the microenvironment of lung tissue and realize the coculture of two kinds of cells at different levels. We used a two-dimensional (2D) well plate and a 3D lung chip to evaluate the effects of different EGFR-targeting drugs (gefitinib, afatinib, and osimertinib) on tumor cells. The 3D lung chip was superior to the 2D well plate at evaluating the effect of drugs on the NCI-H650, and the results were more consistent with existing clinical data. For primary tumor cells, 3D lung chips have more advantages because they simulate conditions that are more similar to the physiological cell microenvironment. The evaluation of EGFR-targeted drugs on lung chips is of great significance for personalized diagnosis and treatment and pharmacodynamic evaluation.Keywords
Funding Information
- Key Research and Development Program of Guangdong Province (2020A111128030)
This publication has 28 references indexed in Scilit:
- Non-small cell lung cancer: current treatment and future advancesTranslational Lung Cancer Research, 2016
- Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trialThe Lancet Oncology, 2016
- A versatile lab-on-a-chip tool for modeling biological barriersSensors and Actuators B: Chemical, 2016
- Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER studyPLOS ONE, 2015
- Modeling human lung development and disease using pluripotent stem cellsDevelopment, 2015
- Organogenesis in a dish: Modeling development and disease using organoid technologiesScience, 2014
- Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancerBiomaterials, 2013
- A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip MicrodeviceScience Translational Medicine, 2012
- Reconstituting Organ-Level Lung Functions on a ChipScience, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009